The efficacy of oxaliplatin, surufatinib, and camrelizumab on neuroendocrine carcinoma: a case report and literature review

BACKGROUND: Extra-pulmonary neuroendocrine carcinomas (EP-NECs) are rare, accounting for ~1/100,000 of NECs, aggressive neoplasms and poor prognosis. Sometimes, a non-neuroendocrine component is also accompanying these EP-NECs. Curative surgery is suggested for early stage patients while system chem...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xianhua, Hu, Shaobo, Su, Fei, Lin, Jie, Duan, Jianghui, Tan, Haidong, Tan, Huangying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761152/
https://www.ncbi.nlm.nih.gov/pubmed/36544653
http://dx.doi.org/10.21037/atm-22-4789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761152/
https://www.ncbi.nlm.nih.gov/pubmed/36544653
http://dx.doi.org/10.21037/atm-22-4789

Ejemplares similares